CD 99 expression is strongly associated with clinical outcome in children with B‐cell precursor acute lymphoblastic leukaemia
Our study aimed to determine the expression pattern and clinical relevance of CD 99 in paediatric B‐cell precursor acute lymphoblastic leukaemia ( BCP ‐ ALL ). Our findings demonstrate that high expression levels of CD 99 are mainly found in high‐risk BCP ‐ ALL , e.g. BCR ‐ ABL 1 and CRLF 2 Re/Hi ,...
Gespeichert in:
Veröffentlicht in: | British journal of haematology 2019-02, Vol.184 (3), p.418-423 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 423 |
---|---|
container_issue | 3 |
container_start_page | 418 |
container_title | British journal of haematology |
container_volume | 184 |
creator | Chen, Dongfeng Camponeschi, Alessandro Wu, Qingqing Gerasimcik, Natalija Li, Huiqi Shen, Xue Tan, Yujie Sjögren, Helene Nordlund, Jessica Lönnerholm, Gudmar Abrahamsson, Jonas Fogelstrand, Linda Mårtensson, Inga‐Lill |
description | Our study aimed to determine the expression pattern and clinical relevance of
CD
99 in paediatric B‐cell precursor acute lymphoblastic leukaemia (
BCP
‐
ALL
). Our findings demonstrate that high expression levels of
CD
99 are mainly found in high‐risk
BCP
‐
ALL
, e.g.
BCR
‐
ABL
1
and
CRLF
2
Re/Hi
,
and that high
CD
99
mRNA
levels are strongly associated with a high frequency of relapse, high proportion of positive for minimal residual disease at day 29 and poor overall survival in paediatric cohorts, which indicate that
CD
99 is a potential biomarker for
BCP
‐
ALL
. |
doi_str_mv | 10.1111/bjh.15683 |
format | Article |
fullrecord | <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1111_bjh_15683</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1111_bjh_15683</sourcerecordid><originalsourceid>FETCH-LOGICAL-c743-ee8896e87e428b32afb16e6966f07e51ea08758f99461365c6bda3596b60d2473</originalsourceid><addsrcrecordid>eNotkL1OwzAUhS0EEqUw8AZ3ZUix48SxRyi_UiWW7pHj3BAXJ47sRNAJHoFn5EloKWc5y9EnnY-QS0YXbJfratMuWC4kPyIzxkWepCxjx2RGKS0SRjN5Ss5i3FDKOM3ZjHwu70ApwI8hYIzW92AjxDH4_tVtQcfojdUj1vBuxxaMs7012oGfRuM7BNuDaa2rA_aHxe3P17dB52DHM1OIPoA204jgtt3Q-srpOFoDDqc3jZ3V5-Sk0S7ixX_Pyfrhfr18SlYvj8_Lm1ViiowniFIqgbLALJUVT3VTMYFCCdHQAnOGmsoil41Smdi_NqKqNc-VqASt06zgc3J1wJrgYwzYlEOwnQ7bktFyL67ciSv_xPFfzhpjug</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>CD 99 expression is strongly associated with clinical outcome in children with B‐cell precursor acute lymphoblastic leukaemia</title><source>Wiley Free Content</source><source>Wiley Online Library All Journals</source><creator>Chen, Dongfeng ; Camponeschi, Alessandro ; Wu, Qingqing ; Gerasimcik, Natalija ; Li, Huiqi ; Shen, Xue ; Tan, Yujie ; Sjögren, Helene ; Nordlund, Jessica ; Lönnerholm, Gudmar ; Abrahamsson, Jonas ; Fogelstrand, Linda ; Mårtensson, Inga‐Lill</creator><creatorcontrib>Chen, Dongfeng ; Camponeschi, Alessandro ; Wu, Qingqing ; Gerasimcik, Natalija ; Li, Huiqi ; Shen, Xue ; Tan, Yujie ; Sjögren, Helene ; Nordlund, Jessica ; Lönnerholm, Gudmar ; Abrahamsson, Jonas ; Fogelstrand, Linda ; Mårtensson, Inga‐Lill</creatorcontrib><description>Our study aimed to determine the expression pattern and clinical relevance of
CD
99 in paediatric B‐cell precursor acute lymphoblastic leukaemia (
BCP
‐
ALL
). Our findings demonstrate that high expression levels of
CD
99 are mainly found in high‐risk
BCP
‐
ALL
, e.g.
BCR
‐
ABL
1
and
CRLF
2
Re/Hi
,
and that high
CD
99
mRNA
levels are strongly associated with a high frequency of relapse, high proportion of positive for minimal residual disease at day 29 and poor overall survival in paediatric cohorts, which indicate that
CD
99 is a potential biomarker for
BCP
‐
ALL
.</description><identifier>ISSN: 0007-1048</identifier><identifier>EISSN: 1365-2141</identifier><identifier>DOI: 10.1111/bjh.15683</identifier><language>eng</language><ispartof>British journal of haematology, 2019-02, Vol.184 (3), p.418-423</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c743-ee8896e87e428b32afb16e6966f07e51ea08758f99461365c6bda3596b60d2473</citedby><cites>FETCH-LOGICAL-c743-ee8896e87e428b32afb16e6966f07e51ea08758f99461365c6bda3596b60d2473</cites><orcidid>0000-0003-1910-1234</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,27907,27908</link.rule.ids></links><search><creatorcontrib>Chen, Dongfeng</creatorcontrib><creatorcontrib>Camponeschi, Alessandro</creatorcontrib><creatorcontrib>Wu, Qingqing</creatorcontrib><creatorcontrib>Gerasimcik, Natalija</creatorcontrib><creatorcontrib>Li, Huiqi</creatorcontrib><creatorcontrib>Shen, Xue</creatorcontrib><creatorcontrib>Tan, Yujie</creatorcontrib><creatorcontrib>Sjögren, Helene</creatorcontrib><creatorcontrib>Nordlund, Jessica</creatorcontrib><creatorcontrib>Lönnerholm, Gudmar</creatorcontrib><creatorcontrib>Abrahamsson, Jonas</creatorcontrib><creatorcontrib>Fogelstrand, Linda</creatorcontrib><creatorcontrib>Mårtensson, Inga‐Lill</creatorcontrib><title>CD 99 expression is strongly associated with clinical outcome in children with B‐cell precursor acute lymphoblastic leukaemia</title><title>British journal of haematology</title><description>Our study aimed to determine the expression pattern and clinical relevance of
CD
99 in paediatric B‐cell precursor acute lymphoblastic leukaemia (
BCP
‐
ALL
). Our findings demonstrate that high expression levels of
CD
99 are mainly found in high‐risk
BCP
‐
ALL
, e.g.
BCR
‐
ABL
1
and
CRLF
2
Re/Hi
,
and that high
CD
99
mRNA
levels are strongly associated with a high frequency of relapse, high proportion of positive for minimal residual disease at day 29 and poor overall survival in paediatric cohorts, which indicate that
CD
99 is a potential biomarker for
BCP
‐
ALL
.</description><issn>0007-1048</issn><issn>1365-2141</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNotkL1OwzAUhS0EEqUw8AZ3ZUix48SxRyi_UiWW7pHj3BAXJ47sRNAJHoFn5EloKWc5y9EnnY-QS0YXbJfratMuWC4kPyIzxkWepCxjx2RGKS0SRjN5Ss5i3FDKOM3ZjHwu70ApwI8hYIzW92AjxDH4_tVtQcfojdUj1vBuxxaMs7012oGfRuM7BNuDaa2rA_aHxe3P17dB52DHM1OIPoA204jgtt3Q-srpOFoDDqc3jZ3V5-Sk0S7ixX_Pyfrhfr18SlYvj8_Lm1ViiowniFIqgbLALJUVT3VTMYFCCdHQAnOGmsoil41Smdi_NqKqNc-VqASt06zgc3J1wJrgYwzYlEOwnQ7bktFyL67ciSv_xPFfzhpjug</recordid><startdate>201902</startdate><enddate>201902</enddate><creator>Chen, Dongfeng</creator><creator>Camponeschi, Alessandro</creator><creator>Wu, Qingqing</creator><creator>Gerasimcik, Natalija</creator><creator>Li, Huiqi</creator><creator>Shen, Xue</creator><creator>Tan, Yujie</creator><creator>Sjögren, Helene</creator><creator>Nordlund, Jessica</creator><creator>Lönnerholm, Gudmar</creator><creator>Abrahamsson, Jonas</creator><creator>Fogelstrand, Linda</creator><creator>Mårtensson, Inga‐Lill</creator><scope>AAYXX</scope><scope>CITATION</scope><orcidid>https://orcid.org/0000-0003-1910-1234</orcidid></search><sort><creationdate>201902</creationdate><title>CD 99 expression is strongly associated with clinical outcome in children with B‐cell precursor acute lymphoblastic leukaemia</title><author>Chen, Dongfeng ; Camponeschi, Alessandro ; Wu, Qingqing ; Gerasimcik, Natalija ; Li, Huiqi ; Shen, Xue ; Tan, Yujie ; Sjögren, Helene ; Nordlund, Jessica ; Lönnerholm, Gudmar ; Abrahamsson, Jonas ; Fogelstrand, Linda ; Mårtensson, Inga‐Lill</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c743-ee8896e87e428b32afb16e6966f07e51ea08758f99461365c6bda3596b60d2473</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chen, Dongfeng</creatorcontrib><creatorcontrib>Camponeschi, Alessandro</creatorcontrib><creatorcontrib>Wu, Qingqing</creatorcontrib><creatorcontrib>Gerasimcik, Natalija</creatorcontrib><creatorcontrib>Li, Huiqi</creatorcontrib><creatorcontrib>Shen, Xue</creatorcontrib><creatorcontrib>Tan, Yujie</creatorcontrib><creatorcontrib>Sjögren, Helene</creatorcontrib><creatorcontrib>Nordlund, Jessica</creatorcontrib><creatorcontrib>Lönnerholm, Gudmar</creatorcontrib><creatorcontrib>Abrahamsson, Jonas</creatorcontrib><creatorcontrib>Fogelstrand, Linda</creatorcontrib><creatorcontrib>Mårtensson, Inga‐Lill</creatorcontrib><collection>CrossRef</collection><jtitle>British journal of haematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chen, Dongfeng</au><au>Camponeschi, Alessandro</au><au>Wu, Qingqing</au><au>Gerasimcik, Natalija</au><au>Li, Huiqi</au><au>Shen, Xue</au><au>Tan, Yujie</au><au>Sjögren, Helene</au><au>Nordlund, Jessica</au><au>Lönnerholm, Gudmar</au><au>Abrahamsson, Jonas</au><au>Fogelstrand, Linda</au><au>Mårtensson, Inga‐Lill</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>CD 99 expression is strongly associated with clinical outcome in children with B‐cell precursor acute lymphoblastic leukaemia</atitle><jtitle>British journal of haematology</jtitle><date>2019-02</date><risdate>2019</risdate><volume>184</volume><issue>3</issue><spage>418</spage><epage>423</epage><pages>418-423</pages><issn>0007-1048</issn><eissn>1365-2141</eissn><abstract>Our study aimed to determine the expression pattern and clinical relevance of
CD
99 in paediatric B‐cell precursor acute lymphoblastic leukaemia (
BCP
‐
ALL
). Our findings demonstrate that high expression levels of
CD
99 are mainly found in high‐risk
BCP
‐
ALL
, e.g.
BCR
‐
ABL
1
and
CRLF
2
Re/Hi
,
and that high
CD
99
mRNA
levels are strongly associated with a high frequency of relapse, high proportion of positive for minimal residual disease at day 29 and poor overall survival in paediatric cohorts, which indicate that
CD
99 is a potential biomarker for
BCP
‐
ALL
.</abstract><doi>10.1111/bjh.15683</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0003-1910-1234</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0007-1048 |
ispartof | British journal of haematology, 2019-02, Vol.184 (3), p.418-423 |
issn | 0007-1048 1365-2141 |
language | eng |
recordid | cdi_crossref_primary_10_1111_bjh_15683 |
source | Wiley Free Content; Wiley Online Library All Journals |
title | CD 99 expression is strongly associated with clinical outcome in children with B‐cell precursor acute lymphoblastic leukaemia |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T17%3A33%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=CD%2099%20expression%20is%20strongly%20associated%20with%20clinical%20outcome%20in%20children%20with%20B%E2%80%90cell%20precursor%20acute%20lymphoblastic%20leukaemia&rft.jtitle=British%20journal%20of%20haematology&rft.au=Chen,%20Dongfeng&rft.date=2019-02&rft.volume=184&rft.issue=3&rft.spage=418&rft.epage=423&rft.pages=418-423&rft.issn=0007-1048&rft.eissn=1365-2141&rft_id=info:doi/10.1111/bjh.15683&rft_dat=%3Ccrossref%3E10_1111_bjh_15683%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |